Antiulcerogenic Effect of Zataria multiflora Boiss. on Cysteamine Induced Duodenal Ulcer in Rats Antiulcerogenic effect of Zataria multiflora
Iranian Journal of Pharmaceutical Sciences,
Vol. 1 No. 4 (2005),
1 October 2005
,
Page 223-229
https://doi.org/10.22037/ijps.v1.39542
Abstract
Research advances during recent years offer new insight into therapy and the prevention of gastrointestinal ulcers by using medicinal plants. Flavonoids, tannins, triterpenoids, fatty acids and essential oils are among the most effective herbal constituents that have potential antiulcerogenic properties, and most of them could be found in Zataria multiflora. Z. multiflora is one of the indigenous plants of Iran,
which is readily available and traditionally used to improve gastrointestinal disorders. In a recent trial, we decided to study the potential antiulcerogenic effects of the plant on an animal model of duodenal ulcer. Hydroalcoholic extract of the plant with doses of 200, 400, 800 and 1200 mg/kg, ranitidine (50 mg/kg), sucralfate (2 g/kg) and 1 ml of the vehicle were administered orally to different groups of male Wistar rats.
Two other groups received (i.p.) vehicle (1 ml) and extract (800 mg/kg). Duodenum ulcers were induced by cysteamine HCl and the number of ulcers, area, and finally ulcer index were assessed. Ranitidine and sucralfate resulted in significant reduction in the duodenal mucosal damage for the entire ulcer factors assessed. Increasing doses of the extract resulted in a significant reduction in ulcerated area and index in a dose dependent manner. We concluded that Z. multiflora extract was effective in protecting against duodenal ulceration, and for the larger doses used, the efficacy was comparable with the reference drugs. The mechanism of action couldn’t be clearly proposed for the plant extract, however; the local mucosal enhancement and cytoprotection may be involved.
- Cysteamine
- Duodenal ulcer
- Zataria multiflora
How to Cite
References
[2] Corelli RL. Gastrointestinal disorders. In: Koda- Kimble MA, Young LY, Kradjan AW, Guglielmo BJ, Alldredge BK, Corelli RL, (editors). Applied therapeutics, the clinical use of dru g s. 8th ed. Philadelphia: Lippincott Williams and Wilkins Company, 2005; pp. 3-27.
[3] Katzung BG. Basic and clinical pharmacology. 8t h ed.. New York: Lange Medical Books/ McGrow Hill Companies, 2001; p. 1064.
[4] Garcia G. Gastrointestinal disorders. In: Curruthers SG, Hoffman BB, Melmon KL, Nierenberg DW, (editors). Melmon and morrellies clinical pharmacology. 4t h ed.. New Yo r k : McGrow Hill Company, 2000; pp. 309-12.
[5] Amin G. Popular medicinal plants of Iran, Vol. 1. Tehran: Iranian Ministry of Health Publications, 1991; p. 40.
[6] Hosseinzadeh H, Ramezani M, Salmani G. Antinociceptive, anti-inflammatory and acute toxicity effects of Zataria multiflora Boiss. extract in mice and rats. J Ethnopharmacol 2000; 73: 379- 85.
[7] Jaffary F, Ghannadi A, Siahpoush A. Antinociceptive effects of hydroalcoholic extract and essential oil of Zataria multiflora. Fitoterapia 2004; 75: 217-20.
[8] Sadraei H, Ghannadi A, Takei-Bavani M. Effects of Zataria multiflora and Carum carvi essential oils and hydroalcoholic extract of Passiflora incarnate, Berberis integrima and Crocus sativus on rat isolated uterus contractions. Internat J Aromather 2003; 13: 121-7.
[9] Ghannadi A, Sajjadi SE, Abedi D, Yousefi J, Daraei-Ardekani R. The in vitro activity of seven Iranian plants of the Lamiaceae family against Helicobacter pylori. Nig J Nat Prod Med 2004; 8: 40-2.
[10] Ziegler HL, Franzyk H, Sairafianpour M, Tabatabaei M, Tehrani MD, Bagherzadeh K, Hagerstrand H, Staerk D, Jaroszewski JW. Erythrocyte membrane modifying agents and the inhibition of Plasmodium falciparum growth: structure-activity relationship for betulinic acid analogues. Bioorg Med Chem 2004; 12: 119-27.
[11] Sardari S, Amin G, Micetich RG, Daneshtalab M. Phytopharmaceuticals: Part I. Antifungal activity of selected Iranian and Canadian plants. Pharm Biol 1998; 36: 180-6.
[12] Mohagheghzadeh A, Shams-Ardakani M, Ghannadi A. Linalol-rich essential oil of Zataria multiflora Boiss. (Lamiaceae). Flavour Fragr J 2000; 15: 119-22.
[13] Ali MS, Saleem M, Akhtar F, Jahangir M, Parvez M, Ahmad VU. Three p-cymene derivatives from Zataria multiflora. P h y t o c h e m i s t ry 1999; 52: 685-8.
[14] Ali MS, Saleem M, Ali Z, Ahmad VU. Chemistry of Zataria multiflora (Lamiaceae). Phytochemistry 2000; 55: 933-6.
[15] Mohagheghzadeh A, Shams-Ardakani M, Ghannadi A, Minaeian M. Rosmarinic acid from Zataria multiflora tops and in vitro cultures. Fitoterapia 2004; 75: 315-21.
[16] Ali MS, Saleem M, Ali Z, Ahmad VU. Zatariol; a new aromatic constituent from Zataria multiflora. Z Naturforsch 1999; 54b: 807-10.
[17] Szabo S. Animal models of human disease: cysteamine induced acute and chronic duodenal ulcers in the rat. Am J Pathol 1978; 93: 273-6.
[18] Desai JK, Goyal RK, Parmar NS. Gastric and duodenal antiulcer activity of SKF-38393, a dopamine D1- receptor agonist in rats. J Pharm Pharmacol 1995; 47: 734-8.
[19] Minaiyan M, Ghafghazi T. Effects of selective dopamine receptor agonists (D1/ D A1) and ( D2/ DA2) on stress induced gastric lesions in rats. Physiol Pharmacol 1999; 1: 1-10.
[20] Vogel HG, Vogel WH. d rug discovery and evaluation (pharmacological assays). Berlin: Springer Verlag, 1997; pp.486-7.
[21] Szabo S, Reynolds ES, Lichtenberger LM, Haith LR, Dzau VJ. Pathogenesis of duodenal ulcer, gastric hyperacidity caused by propionitrile and cysteamine in rats. Res Commun Pathol Pharmacol 1977; 16: 311-23.
[22] Pascaud XB, Chovet M, Soulard P, Chevalier E, Roze C, Junien JL. Effects of a new δ ligand, JO 17847, on cysteamine ulcers and duodenal alkaline secretion in rats. Gastroenterology 1993; 104: 427-34.
[23] Szabo S, Haith LR, Reynolds ES. Pathogenesis of duodenal ulceration produced by cysteamine or propionitrile. Influence of vagotomy, sympathectomy, histamine depletion, H2- receptor antagonists and hormones. Dig Dis Sci 1979; 24: 471-7.
[24] Lichtenberger LM, Szabo S, Reynolds ER. Gastric emptying in the rat is inhibited by the duodenal ulcerogens, cysteamine and propionitrile. Gas - troenterology 1977; 73: 1072-6.
[25] Briden S, Flemstrom G, Kivilaakso E. Cysteamine and propionitrile inhibit the rise of duodenal mucosal alkaline secretion in response to luminal acid in rats. Gastro e n t e rology 1985; 88: 295- 302.
[26] Gallagher G, Brown A, Szabo S. Effect of dopamine related drugs on duodenal ulcer induced by cysteamine or propionitrile: Prevention and aggravation may not be mediated by gastrointestinal secretory changes in the rat. J Pharmacol Exp Ther 1986; 240: 883-9.
[27] Rang HP, Dale MM, Ritter JM. Pharmacology. 4th ed.. Edinburgh: Churchill Livingstone, 1999; p. 376.
[28] Borrelli F, Izzo AA. The plant kingdom as a source of anti-ulcer remedies. Phytother Res 2000; 14: 581-91.
[29] DiCarlo G, Mascolo N, Izzo AA, Capasso F. Flavonoids: Old and new aspects of a class of natural therapeutic drugs. Life Sci 1999; 64: 337- 53.
[30] Chung JG, Hsia TC, Kuo HM, Li YC, Lee YM, Lin SS, Hung CF. Inhibitory actions of luteolin on the growth and arylamine N-acetyltransferase activity in strains of Helicobacter pylori from ulcer patients. Toxicol In Vitro 2001; 15: 191-8.
[31] Alcaraz MJ, Hoult JR. Actions of flavonoids and the novel anti-inflammatory flavon, hypolaetin-8- glucoside, on prostaglandin biosynthesis and inactivation. Biochem Pharmacol 1985; 34: 2477-82.
[32] Salvayre R, Braquet P, Perochot L, Douste-Blazy L. Comparison of the scavenger effect bilberry anthocyanosides with various flavonoids. Flavon Bioflavon 1982; 11: 437-42.
[33] Al-Sereiti MR, Abu-Amer KM, Sen P. Pharmacology of rosemary (R o s m a r i n u s officinalis L.) and its therapeutic potentials. Indian J Exp Biol 1999; 37: 124-30.
[34] Petersen M, Simmonds MSJ. Molecules of interests: rosmarinic acid. Phytochemistry 2003; 62: 121-5.
[35] Ovesna Z, Vachalkova A, Horvatova K, Tothova D. Pentacyclic triterpenic acids: new chemoprotective compounds. Neoplasma 2004; 51: 327-33.
[36] Astadillo L, Rodriguez JA, Schmeda-Hirschman G. Gastroprotective activity of oleanolic acid derivatives on experimentally induced gastric lesions in rats and mice. J Pharm Pharmacol 2002; 54: 583-8.
[37] Barocelli E, Calcina F, Chiavarini M, Impicceatore M, Bruni R, Bianchi A, Ballabeni V. A n t i - nociceptive and gastroprotective effects of inhaled and orally administered Lavandula hybrida Reverchon “Grosso” essential oil. Life Sci 2004; 76: 213-23.
[38] Szabo S, Trier J, Brown A, Schnoor J, Homan HD, Bradford JC. Aquantitative method for assessing the extent of experimental gastric ulcers. J Pharmacol Methods 1985; 13: 59-66.
[39] Wallace JL, Track NS, Cohen MM. Chronic mild restraint protects the rat gastric mucosa from injury by ethanol or cold restraint. G a s t ro e n t e ro l o g y 1983; 85: 370-5.
- Abstract Viewed: 48 times
- IJPS_Volume 1_Issue 4_Pages 223-229 Downloaded: 15 times